Pricing Log in Create free account
Saturday 17 October 2026 Export AMGN’s income statement to Excel — free account

Amgen Inc.

AMGN Healthcare Drug Manufacturers General

Amgen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $36.8 billion, up 9.95% from fiscal 2024. In the quarter to June 2026, revenue grew 9.53%, EPS grew 65.4%, free cash flow grew 82.6% and total debt rose 1.96%, each against the same quarter a year earlier. Member of the S&P 500, Nasdaq 100 and Dow Jones; dividend growth for ten consecutive years, revenue growth for five.

432.49 1.54 −0.35%
Market cap
$234.7B
P/E
26.7×
Fwd P/E
22.7×
Dividend yield
2.30%
F-score
7/9
Altman Z
1.69
Beneish M
−2.27
Dividend safety
56/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Amgen Inc. (AMGN) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Amgen Inc. (AMGN) trades at a P/E ratio of 26.7×. Over the past ten years it has ranged from 13.2× (May 2019) to 75.3× (January 2018); the current reading is higher than 82% of that period. That is above the Drug Manufacturers General industry median of 24.5× and above the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 22.8× (33.22%)
FY2024 34.2× 44.46%
FY2023 23.7× 10.22%
FY2022 21.5× (1.07%)
FY2021 21.7× 17.02%
FY2020 18.6× (0.31%)
FY2019 18.6× 21.35%
FY2018 15.3× (77.21%)
FY2017 67.3× 360.78%
FY2016 14.6× (17.58%)

Quarterly newest first

Period P/E ratio Change
Jun 2026 22.3× (8.12%)
Mar 2026 24.3× 6.38%
Dec 2025 22.8× 5.46%
Sep 2025 21.7× (4.44%)
42 more quarters

Against its own ten years

Low 13.2× High 75.3×
Ten-year median 20.7×
Current reading's percentile 81

P/E ratio against peers

Company P/E ratio
GILD Gilead Sciences, Inc. compare n/m
NVO Novo Nordisk A/S compare 9.5×
BMY Bristol Myers Squibb Company compare 13.2×
NVS Novartis AG compare 22.6×
AZN AstraZeneca PLC compare 24.5×
AMGN Amgen Inc. 26.7×
PFE Pfizer Inc. compare 38.9×
ABBV AbbVie Inc. compare 80.6×
MRK Merck & Co., Inc. compare 117×
Drug Manufacturers General industry median 24.5×
Healthcare sector median 23.0×
Market median 18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on AMGN